Rivastigmine From Capsules to Patch: Therapeutic Advances in the Management of Alzheimer’s Disease and Parkinson’s Disease Dementia

Por Sadowsky, Carl H., Micca, Joseph L., Grossberg, George T., Velting, Drew M.
Publicado no Prim Care Companion CNS Disord (2014)

A practical algorithm for managing Alzheimer's disease: what, when, and why?

Por Cummings, Jeffrey L, Isaacson, Richard S, Schmitt, Frederick A, Velting, Drew M
Publicado no Ann Clin Transl Neurol (2015)

Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer’s disease

Por Micca, Joseph L, Galvin, James E, Velting, Drew M, Meng, Xiangyi
Publicado no SAGE Open Med (2014)

Evaluating Response to High‐Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease

Por Farlow, Martin R., Sadowsky, Carl H., Velting, Drew M., Meng, Xiangyi, Islam, M. Zahur
Publicado no CNS Neurosci Ther (2015)